Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Yon Su Kim, MD"'
Autor:
Stephan Busque, MD, MSc, FRCSC, Flavio G. Vincenti, MD, Helio Tedesco Silva, MD, Philip J. O’Connell, MD, Atsushi Yoshida, MD, John J. Friedewald, MD, Steven M. Steinberg, MD, Klemens Budde, MD, Emine N. Broeders, MD, Yon Su Kim, MD, Carolyn M. Hahn, BA, Huihua Li, MS, Gary Chan, PharmD
Publikováno v:
Transplantation Direct, Vol 4, Iss 9, p e380 (2018)
Background. Tofacitinib is an oral Janus kinase inhibitor. This open-label, long-term extension (LTE) study (NCT00658359) evaluated long-term tofacitinib treatment in stable kidney transplant recipients (n = 178) posttransplant. Methods. Patients who
Externí odkaz:
https://doaj.org/article/b0a113a41fb849ff85e357bd02831398
